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Abstract
Aims: Hydrogen sulfide (H2S) is a signaling molecule, which influences many physiological processes. While
H2S is produced and degraded in many cell types, the kinetics of its turnover in different tissues has not been
reported. In this study, we have assessed the rates of H2S production in murine liver, kidney, and brain
homogenates at pH 7.4, 37C, and at physiologically relevant cysteine concentrations. We have also studied the
kinetics of H2S clearance by liver, kidney, and brain homogenates under aerobic and anaerobic conditions.
Results: We find that the rate of H2S production by these tissue homogenates is considerably higher than
background rates observed in the absence of exogenous substrates. An exponential decay of H2S with time is
observed and, as expected, is significantly faster under aerobic conditions. The half-life for H2S under aerobic
conditions is 2.0, 2.8, and 10.0 min with liver, kidney, and brain homogenate, respectively. Western-blot analysis
of the sulfur dioxygenase, ETHE1, involved in H2S catabolism, demonstrates higher steady-state protein levels in
liver and kidney versus brain. Innovation: By combining experimental and simulation approaches, we dem-
onstrate high rates of tissue H2S turnover and provide estimates of steady-state H2S levels. Conclusion: Our
study reveals that tissues maintain a high metabolic flux of sulfur through H2S, providing a rationale for how
H2S levels can be rapidly regulated. Antioxid. Redox Signal. 17, 22–31.
Introduction
H2S is an endogenously produced signaling moleculethat modulates varied physiological processes. It in-
duces relaxation of vascular smooth muscle cells by opening
ATP-sensitive potassium channels (47), enhances NMDA
receptor-sensitivity to neurotransmitters and facilitates the
induction of long-term potentiation in hippocampal neurons
(1), protects from myocardial ischemia-reperfusion injury (9),
inhibits cell proliferation (46), and reduces mitochondrial
respiration by reversibly inhibiting cytochrome c oxidase and
induces a suspended animation-like metabolic state (3, 4).
H2S is a potent inhibitor of cytochrome c oxidase and there-
fore, toxic for aerobic life at high concentrations (4). Because
of its signaling role and toxicity, tissue H2S levels must
be tightly regulated. However, the mechanisms underlying
H2S homeostasis (i.e., its production and clearance) are not
well understood.
H2S is primarily generated by two PLP-dependent en-
zymes in the transsulfuration pathway (Fig. 1), cystathionine
b-synthase (CBS) and cystathionine c-lyase (CSE), which
employ cysteine and homocysteine as substrates (20, 33). A
third enzyme proposed to contribute to H2S production, is 3-
mercaptopyruvate sulfur transferase (MST). However, this
reaction requires a reducing agent to release H2S from the
Innovation
The technical challenges associated with H2S measure-
ment have led to widely varying reports of steady-state
concentrations spanning a range over five orders of mag-
nitude. Similarly, measures of H2S biogenesis and removal
rates, which determine the steady-state concentrations in
tissues, have yielded widely varying values. For H2S to
exert a signaling role, mechanisms for rapid regulation of
its concentration in response to environmental/cellular
cues (e.g., oxygen concentration) must exist. However, the
virtual absence of kinetic data has limited insights into H2S
turnover in tissues, and therefore, strategies for its regu-
lation. We demonstrate that robust rates of H2S production
in murine liver, kidney, and brain at physiologically rele-
vant cysteine concentrations and pH. The high H2S gen-
erating flux is countered by rapid H2S clearance under
aerobic conditions accounting for very low steady-state
tissue H2S levels. Consequently, even small deviations in
the rates of H2S production and/or clearance are expected
to lead to rapid and several fold changes in H2S levels. The
kinetics of H2S metabolism thus provides for fast and
effective regulation of H2S levels in tissues, an essential
feature for a signaling molecule.
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enzyme-bound persulfide formed from the substrate, mer-
captopyruvate (20, 29).
H2S catabolism occurs via a mitochondrial sulfide oxida-
tion pathway (Fig. 1) and is coupled to energy production (15,
17). In the first step, H2S is oxidized by a mitochondrial
membrane-bound flavoprotein, sulfide quinone oxidoreduc-
tase (SQR), which forms a protein-bound persulfide while the
electrons are transferred to ubiquinone. In the second step, a
sulfur dioxygenase (ETHE1) oxidizes SQR-bound sulfane
sulfur to sulfite, which is subsequently converted to thiosul-
fate by the transfer of a second persulfide equivalent cata-
lyzed by the sulfur transferase, rhodhanese. In some
organisms, thiosulfate is metabolized to sulfate by thiosulfate
reductase (27). Alternatively, sulfite can be oxidized to sulfate
by sulfite oxidase.
In tissues, an unknown fraction of H2S exists in the bound
state, generated by nucleophilic attack of the hydrosulfide
anion on cysteine disulfide or sulfenic acid, forming cysteine
persulfide. While the resulting persulfides are stable under
oxidizing conditions, in the reducing cellular milieu, they
need to be sequestered from disulfide exchange reactions
initiated by proximal cysteine residues on proteins or by ex-
ogenous thiolates (e.g., cysteine or glutathione) or antioxidant
enzymes (e.g., thioredoxin). In brain, protein-bound sulfide
constitutes a significant proportion of the sulfide pool that
may: 1) serve to sequester H2S, thereby protecting cells from
its toxic effect, and 2) function as a stored H2S pool that can be
mobilized to generate free H2S upon demand (19).
An additional sink for H2S in cells is heme-containing
proteins. In invertebrates that live in sulfide-rich environ-
ments, globins bind H2S with high affinity and carry bound
sulfide to symbiotic sulfide-oxidizing bacteria, thereby
avoiding toxicity associated with high H2S concentrations
(41). Depending on the polarity of the hemoglobin active site,
heme-bound sulfide can either dissociate reversibly (from
nonpolar active sites), or reduce ferric to ferrous heme and
release a sulfide radical (HS, from polar active sites) (32).
However, the affinity of mammalian heme proteins for sulfide
is low (30, 31), making it unlikely that globins represent a
significant sink for H2S.
Steady state H2S levels in tissues is governed by the rates of
its production and removal and are very low; 14–17 nM in
liver and brain (12). The literature on H2S production rates by
mammalian tissues is confusing since the data have been
obtained under a variety of conditions including non-
physiological pH (12, 25), high substrate concentrations (8, 12,
21, 25), or in samples fixed with 10% trichloracetic acid (1, 47),
which releases sulfide from iron–sulfur cluster-containing
proteins, leading to overestimation. The rate of H2S produc-
tion by tissue extracts decreases dramatically under aerobic
versus anaerobic conditions even at a very high concentration
of cysteine (10 mM), indicating efficient oxygen-dependent
H2S consumption (12).
Homocysteine concentration in mammalian tissues is esti-
mated to be *1–10 lM (18), while the concentration of cys-
teine is *100 lM in liver and brain, and up to 1.0 mM in
kidney (37, 40). Kinetic data and simulation analyses indicate
that at physiologically relevant substrate concentrations
(10 lM homocysteine and 100 lM cysteine), CBS generates
H2S mainly via condensation of cysteine and homocysteine
while CSE generates H2S primarily via a,b-replacement of
cysteine (7, 34). Since CSE is significantly more abundant than
CBS in murine liver and kidney (21), one can conclude that
cysteine is the primary substrate for H2S production in these
tissues.
H2S oxidation capacity has been reported for different tis-
sues and cells (8, 13, 15, 22, 23, 42). In some of these studies,
H2S degradation was monitored indirectly [i.e., by formation
of thiosulfate and sulfate (13) or by oxygen consumption (15,
23)]. Reports on direct measurements of H2S degradation are
limited to cultured rat aorta smooth muscle cells (8), rat aorta
tissue (22, 42), and blood from several vertebrate species (42).
Thus, to our knowledge, direct measurements of the kinetics
of H2S clearance in several major mammalian tissues (e.g.,
liver, kidney, and brain) are not available. The highest H2S
oxidation rate was found in colon, which needs to detoxify
large quantities of H2S produced by colonic bacteria rapidly.
By comparison, H2S oxidation activity of liver, muscle, and
erythrocytes is *4, 20, and 60-fold lower, respectively, than
colon (13).
In this study, we have compared the kinetics of H2S pro-
duction and clearance by murine liver, kidney, and brain
homogenates at physiologically relevant substrate concen-
trations. Our study provides evidence for high rates of H2S
turnover and provides estimates of steady-state H2S levels in
different tissues.
Results
Dependence of H2S production rates on cysteine
concentration and at pH 5.8 versus 7.4
A pH of 5.8 was previously used for tissue H2S analysis (12,
24) since at this pH, the equilibrium between the ionized (HS-)
and gaseous (H2S) forms is shifted to gas, facilitating H2S
quantitation. However, the effect of this relatively low pH on
the balance between H2S production and clearance rates is not
known and could potentially perturb the tissue H2S produc-
tion rates that were measured. We therefore examined the
effect of pH 5.8 versus 7.4 on H2S production and clearance in
murine tissues. H2S was analyzed by gas chromatography
with a sulfur chemiluminescence detector, which provides
very high sensitivity and reliable detection of H2S even in very
dilute samples (12).
Detectable rates of H2S production were observed at
physiologically relevant cysteine concentrations (0.1–1.0 mM)
at pH 7.4 using mouse liver, kidney, and brain homogenates
(Fig. 2) and H2S accumulation is linear with time in this
FIG. 1. Scheme showing H2S metabolism in mammalian
cells. CAT, cysteine aminotransferase.
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concentration range (not shown). At any cysteine concentra-
tion, the rate of H2S production by liver homogenate is sig-
nificantly higher than for kidney or brain. The rates of H2S
production are comparable for kidney and brain at cysteine
concentrations between 0.1 and 1.0 mM, but are higher in
kidney at 5.0 mM cysteine (Figs. 2B and 2C, insets). In all cases,
a low rate of H2S production was observed even in the ab-
sence of exogenous cysteine and probably resulted from the
presence of low endogenous cysteine in the tissue samples.
The background rate of H2S generation was 21 – 14 (n = 7),
13 – 2 (n = 3), and 12 – 2 (n = 5) lmoles h - 1 kg tissue - 1 in liver,
kidney, and brain, respectively. In liver and brain, even at
0.1 mM cysteine, the rate of H2S production was significantly
higher compared to the background rate ( p < 0.002) and val-
ues of 484 – 271 (n = 7) and 29 – 7 (n = 4) lmoles h - 1 kg tissue - 1
respectively, were obtained. In kidney, a statistically signifi-
cant ( p < 0.03) increase in the H2S production over the back-
ground rate was observed only at ‡ 0.5 mM cysteine; a value
of 104 – 44 (n = 3) lmoles h - 1 kg tissue - 1 was obtained at
0.5 mM cysteine.
For comparison, the rate of H2S production was tested at pH
5.8 with liver homogenate and found to be significantly lower
and in fact, negligible at physiologically relevant cysteine
concentrations. The background rate of H2S formation was
9.0 – 1.2 (n = 5) lmoles h - 1 kg tissue - 1. H2S production rates of
21.0 – 6.3 lmoles h - 1 kg tissue - 1 (n = 3) and 56.2 – 26.3 lmoles
h - 1 kg tissue- 1 (n = 5) were obtained at 0.5 and 1.0 mM cys-
teine concentrations, respectively. We used 100 mM HEPES
buffer for the pH 7.4 measurements since our previous in vitro
kinetic studies on H2S production by purified CBS and CSE
were conducted under those conditions (7, 34). To ensure that
the low H2S production rate at pH 5.8 was not due to a dif-
ference in buffers employed at the two pH values, the analysis
was repeated at pH 7.4 with 100 mM potassium phosphate
buffer. The rate of H2S production was found to be indepen-
dent of buffer but dependent on pH (not shown).
H2S clearance in the presence of oxidants
In control experiments (i.e., in buffer lacking tissue ho-
mogenate), we found that the concentration of H2S decreased
relatively slowly. Surprisingly, the kinetics of H2S disap-
pearance in buffer under anaerobic and aerobic conditions
were comparable over a 20-min time period (Fig. 3). Addition
of 1.0 mM glutathione disulfide (GSSG) or 0.5 mM cystine to
the buffer did not alter the kinetics of H2S disappearance (Fig. 3).
Interestingly, significant activation of H2S degradation was
observed with buffer containing 1.0 mM cystamine (Fig. 3).
H2S clearance in the presence of murine tissues
In the presence of tissue homogenate, H2S disappeared
rapidly under aerobic conditions with the kinetics being fast









FIG. 2. Dependence of H2S production rates on cysteine
concentrations. H2S generation was monitored at 37C in
100 mM HEPES buffer, pH 7.4 (closed circles) or 100 mM so-
dium phosphate buffer, pH 5.8 (open circles) using murine
liver (A), kidney (B), and (C) brain homogenates. Insets show
the dependence of H2S production over an extended cysteine
concentration range. Data represent the mean – SD of 3–7
independent experiments. In liver and brain homogenates at
pH 7.4, the rates of H2S production were significantly higher
( p < 0.002) at all concentrations of cysteine compared to the
background rates in the absence of exogenous cysteine. In
kidney homogenate at cysteine concentrations ‡ 0.5 mM, the
rates of H2S production were significantly higher ( p < 0.03)
compared to background rates, while at 0.2 mM cysteine, the
rate of H2S production was not significantly different from
the background rate ( p > 0.07).




























FIG. 3. Kinetics of H2S disappearance in the presence of
small-molecule oxidants. The kinetics of H2S disappearance
was monitored in control samples containing 500 ll of
100 mM HEPES buffer, pH 7.4. The sample contained in a
total volume of 20 ml, 10 ml of H2S (40 ppm) in nitrogen and
either 9.5 ml of nitrogen (filled symbols) or 9.5 ml of air (open
symbols). The rate of disappearance of H2S was monitored at
25C in presence of either buffer alone (circles) or buffer
containing 1 mM GSSG (triangles), or 0.5 mM cystine (inverted
triangles), or 1 mM cystamine (squares). The lines represent
exponential fits to the data sets. The data represent
means – SD of 3–4 independent experiments.
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the exponential decay in H2S levels occurred more rapidly
under aerobic versus anaerobic conditions. Under aerobic
conditions, H2S levels tended to zero with half-lives of 2.0, 2.8,
and 10.0 min for liver, kidney, and brain homogenates, re-
spectively. The kinetics of H2S clearance were not affected by
the presence of a metal chelator [50 lM DTPA (diethylene-
triamine pentaacetic acid)] in either 100 mM HEPES, pH 7.4 or
100 mM sodium phosphate, pH 5.8 (Supplementary Fig. S1;
supplementary data are available online at www.liebertonline
.com/ars).
Under anaerobic conditions, the exponential fits yielded
non-zero values for final H2S concentrations. In kidney and
brain samples, the final H2S concentrations were similar and
relatively high (64%–68% of the original value with half-lives
corresponding to 1.8 and 2.9 min, respectively), but lower in
liver samples (16% with half-life of 5.4 min). A high degree of
variability was consistently observed with liver, for reasons
that are presently unclear. The effect of pH was studied with
liver extract (Fig. 4A). In comparison to pH 7.4, the rate of H2S
disappearance was only slightly lower at pH 5.8 and this was
not due to the difference between HEPES versus phosphate
buffer used at pH 7.4 versus 5.8, respectively (data not shown).
To exclude oxygen more rigorously, the kinetics of H2S
removal by liver and kidney samples were determined under
strictly anaerobic conditions inside an OMNI-LAB anaerobic
chamber (0.2–0.5 ppm O2 concentration). The slow disap-
pearance of H2S with buffer was again observed under these
conditions (Table 1) as seen previously (Fig. 3). With kidney
homogenate, H2S levels were *20% higher than with buffer
alone. In contrast, H2S levels decreased significantly in the
presence of liver homogenates compared to control samples,
although the decrease was not as large as under standard
anaerobic conditions. Flushing liver homogenates with CO
for 10 min did not alter H2S levels, while addition of 2 mM
dithiothreitol slightly decreased the rate of H2S removal
under strictly anaerobic conditions.
H2S clearance by fresh versus frozen
liver homogenates
To assess the role of mitochondrial integrity on H2S clear-
ance, the kinetics of aerobic H2S degradation was compared in
Table 1. Disappearance of H2S Under Aerobic and Anaerobic Conditions
Sample/conditions
Percent H2S





Aerobic buffer 84.8 – 5.1 6 The difference between all the buffer
data is not significant p > 0.1Anaerobic buffer 81.4 – 2.8 7
‘‘Strictly’’ anaerobic buffer 82.7 – 2.2 7
‘‘Strictly’’ anaerobic kidney homogenate 100.1 – 7.9 3 The difference between kidney and
all the buffer data is significant
p < 0.01
‘‘Strictly’’ anaerobic liver homogenate 51.8 – 21.5 6 The difference between all the liver
data is not significant p > 0.1
The difference between all the liver
and buffer data is significant p < 0.02
‘‘Strictly’’ anaerobic liver homogenate
flushed with CO
63.1 – 12.8 3
‘‘Strictly’’ anaerobic liver homogenate + 2 mM DTT 71.0 – 8.9 4
H2S levels were monitored after 20 min at 25C, in the following samples: aerobic buffer, anaerobic buffer, buffer in an anaerobic chamber
(‘‘strictly’’ anaerobic), kidney homogenate in anaerobic chamber, liver homogenate in anaerobic chamber, liver homogenate flushed with CO
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FIG. 4. Kinetics of H2S disappearance in the presence of
murine tissue homogenates. The kinetics of H2S disap-
pearance was monitored at 25C in a total volume of 20 ml
containing 500 ll murine liver (A), kidney (B), and brain (C)
homogenates, 10 ml of H2S (40 ppm) in nitrogen and 9.5 ml of
nitrogen (filled symbols) or air (open symbols). With the liver
samples, the kinetics of H2S disappearance was measured at
pH 7.4 (circles) and pH 5.8 (triangles). The lines represent
exponential fits to the experimental data sets. The data rep-
resent means – SD of 5–10 independent experiments.
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homogenates prepared from freshly-isolated versus snap-
frozen liver. Exponential decay kinetics were observed in both
samples and t1/2 values of 0.8 and 1.5 min were obtained for
homogenates prepared from fresh and frozen liver, respec-
tively (Supplementary Fig. S2). However, if homogenate from
freshly-isolated liver was stored on ice, H2S decay kinetics
slowed with time, and following a 1 h incubation, coincided
with the kinetics observed with homogenate from frozen liver
(Fig. S2). In contrast, the kinetics of H2S degradation obtained
with homogenates prepared from frozen liver were stable
over a 1–2 h period.
Expression of ETHE1 protein in murine tissues
Western blot analysis revealed two bands that cross react
with purified anti-human ETHE1 antibody in murine liver
and kidney samples, while a laddering of bands was observed
in brain samples (Fig. 5). The lowest band has a molecular
mass of *25 kDa and corresponds to purified recombinant
human ETHE1 lacking the mitochondrial targeting sequence.
The intensity of this band in liver and kidney samples is ap-
proximately equal, but it is barely visible in the brain sample.
The upper band has a molecular mass of *37 kDa and is more
intense than the lower band in the brain sample. It is not
known whether this band represent a cross-reacting protein
or a modified form of ETHE1.
Discussion
The study of H2S production and clearance kinetics is im-
portant since the balance between these rates determine
steady-state H2S levels in tissues. Furthermore, regulation of
either one of these processes, or both, represents a mechanism
for modulating H2S levels. The rate of H2S production in
different mammalian tissues remains a subject of discussion.
Very low rates of H2S production were reported for liver and
brain tissue even at unphysiologically high (10 mM) cysteine
concentrations (12). In fact, production of H2S by liver ho-
mogenates could not be detected below 10 mM cysteine in
these studies (12, 25). However, these experiments were
conducted at pH 5.8 (to enhance protonation of the sulfide
anion to generate H2S) and/or under aerobic conditions (12,
25). In our study, we report that the rate of H2S production by
mammalian tissues is significantly lower at pH 5.8 versus 7.4.
This is expected since the pH optima of enzymes responsible
for H2S biogenesis are reported to be 8.5 for CBS (11), 8.2 for
CSE (35), and 9.0–10.0 for MST (38, 44). Furthermore, since the
mitochondrial pathway for H2S catabolism is oxygen depen-
dent, aerobic conditions are expected to increase H2S con-
sumption competing with the rate of H2S production.
Significant rates of H2S production by liver and brain ho-
mogenates were detected under anaerobic conditions at pH
7.4 with 0.1 mM cysteine, which represents a physiologically
relevant concentration for these tissues (37, 40). In kidney,
where steady-state cysteine levels can be as high as 1.0 mM
(36, 40), H2S production was detected only at ‡ 0.5 mM cys-
teine at pH 7.4. At pH 5.8, measurable H2S production by liver
homogenate was detected only at ‡ 0.5 mM cysteine. The low
H2S accumulation observed in the absence of exogenous
cysteine likely derives from endogenous cysteine present in
samples. During preparation of homogenates, the tissues
were diluted 10-fold (mass/volume) with buffer and the re-
sulting cysteine concentrations were expected to be
*0.01 mM in liver and brain samples and 0.1 mM in the
kidney sample. Release of H2S from the bound sulfide pool is
unlikely to occur at pH 7.4 and in the absence of reductants.
H2S production rates were also measured under anaerobic
conditions, where H2S consumption should be suppressed.
However, even under anaerobic conditions, significant H2S
clearance was observed (Fig. 4) and H2S concentrations de-
creased *30%–40% in kidney and brain homogenates over
the observation time course, and even further in liver ho-
mogenates (Fig. 4). Thus, the rates of H2S production obtained
in our experiments represent an underestimation.
One mechanism for regulating H2S levels is via sulfide
catabolism, which is catalyzed by an oxygen-dependent mi-
tochondrial pathway (Fig. 1). Under aerobic conditions and in
the absence of tissue samples, oxidation of H2S in buffer was
negligible over a 20-min period (Fig. 3). Since the rate of H2S
depletion in the absence of tissue is similar under aerobic and
anaerobic conditions, we attribute the observed loss to leak-
age from the syringe and/or to interactions of sulfide with the
plastic ware. In principle, depletion of H2S in the presence of
tissue homogenates can occur by oxidation or via reaction
with disulfides such as GSSG or cystine, producing persul-
fide. In liver and kidney, GSSG concentrations are relatively
high (in the hundreds of micromolar range (40)) while cystine
levels are very low in liver and brain but *100 lM in kidney
(6). Thus, these metabolites could affect the rate of tissue H2S
concentration. However, neither 1.0 mM GSSG nor 0.5 mM
cystine in buffer at pH 7.4 had a measurable effect on the rate
of H2S loss (Fig. 3). Based on the reported rates of reaction of
H2S with oxidized thiols (10), < 1% of the total H2S is expected
to be consumed in reaction with GSSG under our experi-
mental conditions.
Interestingly, a decrease in H2S levels was observed in the
presence of 1.0 mM cystamine, the oxidized form of cyste-
amine, which is produced during coenzyme A catabolism.
The tissue concentration of cystamine however, is low (in the
micromolar range), making this an unlikely sink for H2S.
FIG. 5. Western blot analysis of ETHE1 expression in
murine liver, kidney and brain. Tissue extracts (100 lg of
protein/lane) was separated on a denaturing 12% poly-
acrylamide gel and detected with anti-human ETHE1 anti-
body as described under Methods. A sample of purified
recombinant human ETHE1 (5 ng) lacking the mitochondrial
leader sequence was used as a positive control. The positions
of molecular weight standards at 25, 37, and 50 kDa are
indicated.
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The rate of aerobic H2S clearance by liver homogenates
observed in our experiments is similar to the rate of liver
sulfate plus thiosulfate production reported previously (13).
In all three tissue homogenates, loss of H2S occurs more
rapidly under aerobic conditions due to the coupling of the
first enzyme, SQR to the electron transport chain and the di-
rect dependence on oxygen of ETHE1, the second enzyme
(Fig. 1). Liver and kidney mitochondria possess high SQR
activity, in contrast to brain mitochondria where the activity is
low (23). Our Western blot data (Fig. 5) reveal high ETHE1
expression levels in liver and kidney, while in brain, the 25 kD
band corresponding to ETHE1 is very weak. The identity of
the 37 kDa cross-reacting band is presently not known. One
possibility is that it represents modified forms of ETHE1. Even
if we assume that all cross-reacting bands correspond to active
ETHE1, it is clear that the sum of band intensities in liver or
kidney samples is significantly higher than in brain sample.
The reported tissue abundance of other enzymes involved in
H2S degradation [i.e., rhodanese and sulfite oxidase in mam-
mals (28, 45)] corresponds to the relative aerobic H2S degra-
dation activity observed in our study.
The weak pH dependence of the observed H2S degradation
rate was surprising. To our knowledge, the pH dependencies
of the activities of mammalian SQR and ETHE1 have not been
reported. SQR from the archaeon Acidianus ambivalens shows
maximal activity at pH 6.0 and *30% activity at pH 7.4 (5).
Murine rhodanese exhibits maximal activity between pH 5–6
and *25% activity at pH 7.4 (39) and human sulfite oxidase
has maximal activity in a wide pH range from 7.0–9.5 with
50% activity at pH 6.0 (43). Thus, based on the available pH
dependence data, the activities of the enzymes involved in
mitochondrial sulfide catabolism might be expected to be
weakly dependent on pH in the 5.8–7.4 range. Furthermore,
the interaction of the enzymes in the sulfide oxidation path-
way might also modulate their pH dependence.
Since H2S turnover was studied in homogenates prepared
from snap-frozen tissues, it is possible that during thawing,
mitochondria might have been damaged. The kinetics of aero-
bic H2S degradation in homogenates prepared from freshly
isolated versus snap-frozen and thawed liver was compared
(Fig. S2). A *2-fold higher rate of H2S clearance was observed
together with a time-dependent decrease in the H2S degrada-
tion rate upon incubation of the homogenate from freshly iso-
lated liver on ice. Thus, mitochondrial integrity is not required
for the activity of the aerobic sulfide-catabolism pathway.
The slower loss of H2S in the presence of tissue homoge-
nates under anaerobic conditions is probably due to the in-
complete removal of oxygen from the samples. However, the
explanation is likely to be more complex since it does not
account for the tissue-dependent differences in H2S disap-
pearance rates under anaerobic conditions (Fig. 4). Reaction of
H2S with disulfides or metals present in tissue samples might
be another mechanism for H2S depletion. However, we did
not observe significant reaction of H2S with disulfides in
control experiments (Fig. 3). Furthermore, the presence of the
metal chelator, DTPA, did not affect the rate of H2S clearance,
indicating that protein-bound versus free metals are more
likely to contribute to H2S binding. Rapid disappearance of
H2S has been reported in the presence of 5% solution of BSA
under anaerobic conditions (42). Thus, under anaerobic con-
ditions H2S can disappear at least in part due to reaction with
proteins in tissue homogenates. This is supported by our
observation that under ‘‘strictly’’ anaerobic conditions, DTT
decreases the rate of H2S degradation (Table 1). It is likely that
the partitioning of H2S between clearance pathways differ
between liver, kidney, and brain since H2S removal by kidney
samples was not observed under strictly anaerobic conditions
(Table 1). Rather, an increase in H2S levels was observed
compared to controls, probably due to H2S production from
endogenous tissue cysteine (Fig. 4). While H2S produced from
endogenous cysteine is rapidly degraded under aerobic con-
ditions, under ‘‘strictly’’ anaerobic conditions where the oxy-
gen concentration is very limited, H2S production in kidney
homogenate (containing the *10-fold higher cysteine levels
compared to the other tissues) might be sufficiently high so
that H2S levels are maintained steady under our experimental
conditions (Table 1). The lower endogenous cysteine levels
in liver homogenate, together with higher H2S degradation
activity, accounts for the observed decrease in H2S levels in
this sample even under ‘‘strictly’’ anaerobic conditions.
Based on the tissue H2S production and clearance rates at
physiologically relevant concentrations of cysteine deter-
mined in this study, an estimate of steady-state tissue H2S
levels can be obtained. The exponential decay of H2S in the
presence of tissue homogenate indicates that the rate of H2S
clearance is a linear function of its concentration (Equation 1).
Vd¼Kexp[H2S] [Eq:1]
Here Vd denotes the rate of H2S clearance and Kexp is a
reaction constant under our experimental conditions. This
constant can be calculated from the half-time (T1/2) of H2S, as
shown in Equation 2.
Kexp¼ ln(2)=T1=2 [Eq:2]
At pH 7.4 and in the presence of air (Fig. 4), the T1/2 value
for liver homogenate is 2.0 min and Kexp = 0.347 min - 1. Nor-
malizing for tissue dilution (the sample contained 50 mg tis-
sue in 20 ml of total volume, which is equivalent to 2.5 g tissue
in 1 L of total volume or 0.25% of liver density), a KL of
(0.347 min - 1 x 400) or 138.8 min - 1 is obtained. Based on a Q10
of *2, the rate constant is estimated to be 277 min - 1 at 37C.
The rate of H2S clearance by liver, VcL, is described by
Equation 3.
VcL¼ 277[H2S]min 1 [Eq:3]
Under steady-state conditions, the rate of H2S clearance
must be equal to the rate of H2S production (Vp), that is,
8.1 lmoles min - 1 kg tissue - 1. Substituting this value for VcL
in Equation 3, an estimate of 29 nmoles kg tissue - 1 for the
steady-state concentration of H2S in murine liver is obtained.
Similarly, the steady-state concentration of H2S can be esti-
mated for kidney (at 0.5 mM cysteine) and brain (at 0.1 mM
cysteine). Values of 8.7 nmoles kg tissue - 1 and 18 nmoles kg
tissue - 1 for kidney and brain, respectively, are obtained from
this analysis. Using the value for the H2S clearance rate by
fresh liver homogenate, we obtain a T1/2 of 0.8 min and an
estimated steady-state H2S concentration in liver of 12 nmoles
kg tissue - 1. These estimates are consistent with the low na-
nomolar tissue concentrations of H2S that have been reported
(12) and emphasize the importance of careful sample prepa-
ration for correct analysis of tissue H2S levels.
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Materials and Methods
Materials
Cysteine, cystine dihydrochloride, cystamine dihy-
drochloride, diethylenetriamine pentaacetic acid, and GSSG
were from Sigma. HEPES and sodium phosphate (monobasic)
were from Fisher Scientific. Buffers were prepared with
deionized water obtained with Milli-Q Advantage A 10 Sys-
tem (Millipore). The pH of buffers was adjusted with sodium
hydroxide (Acros Organics). Nitrogen, carbon monoxide
(Ultra High Purity grade) and H2S standard (40 ppm
(1.785 lmole L - 1)) in nitrogen were obtained from Cryogenic
Gases (Detroit, MI). Polypropylene syringes (Norm-Ject) were
obtained from Fisher Scientific, plastic 3-way stopcocks
were obtained from Smiths Medical, sleeve stopper septa
were from Sigma, and Tedlar gas sample bags, used for H2S
sample handling were obtained from Jensen Inert.
Animals and tissue collection
Male Balb/c mice (2-month-old) were purchased from the
Jackson Laboratory (Bar Harbor, ME). Animals were sacri-
ficed in a CO2 atmosphere, and liver, kidney, and brain were
collected immediately, frozen in liquid nitrogen and stored at
- 80 oC until further use. All procedures for animal handling
were performed in accordance with the protocols approved
by the University’s Committee on Use and Care of Animals.
H2S production assays
Frozen mouse tissue was disrupted at 0C using a glass
homogenizer in 100 mM HEPES buffer, pH 7.4, or in 100 mM
sodium phosphate buffer, pH 5.8, to obtain a tissue concen-
tration of 100 mg/ml. Reactions for H2S production were
prepared in polypropylene syringes as described previously
(12). Tissue homogenate (400 ll), buffer, and cysteine (stock
solutions prepared in buffer) were mixed in 20 ml syringe
barrels in a total liquid volume of 0.5 ml to give final cysteine
concentrations of 0.0, 0.1, 0.2, 0.5, 1.0, and 5.0 mM. Syringes
were sealed with plungers and made anaerobic by flushing
the headspace with nitrogen five times using a 3-way stop-
cock, and then left with nitrogen in a final total volume (liq-
uid + gas) of 20 ml. Syringes were placed in an incubator at
37C with gentle shaking (75 rpm) for 20 min. Control reac-
tions in which buffer replaced tissue homogenate, were pre-
pared in parallel. Aliquots of 200 ll from the gas phase of the
reaction syringes were collected using gas tight syringes
through a septum attached to the stopcock, and injected into
an HP 6890 gas chromatograph (GC) (Hewlett Packard)
equipped with a DB-1 column (30 m x 0.53 mm x 1.0 lm). The
carrier gas (helium) flow rate was 2 ml/min and a tempera-
ture gradient ranging from 30–110C over 20 min was
employed. For samples containing high H2S concentrations, a
20-fold dilution with nitrogen was used to prevent column
overloading. H2S was detected using a 355 sulfur chemilu-
minescence detector (Agilent).
The H2S standard from Cryogenic Gases had a stock con-
centration of 40 ppm (1.785 lmole L - 1) in nitrogen. Aliquots
(200 ll) of varying H2S dilutions in nitrogen were injected into
the GC to generate a standard curve. The amount of H2S in the
injected sample was calculated from the peak areas using the
calibration coefficient obtained from the standard curve. Ac-
counting for the gas fraction in reaction volume (19.5 ml),
gives the total amount of H2S in the gas phase of the reaction
syringe. Note that total H2S was distributed between gas and
liquid (homogenate) phases, and dissolved H2S is present as a
mixture of the ionized form (HS-) and protonated form (H2S),
which in turn, is in equilibrium with H2S in the gas phase. The
amount of dissolved H2S was calculated by multiplying the
concentration of H2S in the gas phase by 1.6, the ratio between
the concentration of H2S in the gas and liquid phases at 37C
(12) and by the liquid volume (0.5 ml). The HS- ion concen-
tration in the liquid phase was calculated using a pKa of 6.8
for ionization of H2S in water at 37C (16). The total amount of
H2S in the reaction mixture was calculated as the sum of H2S
in the gas phase and of dissolved H2S and SH
-. The sum of H2S
in both phases produced in blank reactions lacking tissue was
subtracted from that of reactions containing tissue. The re-
sulting H2S concentration was then used to obtain the specific
activity for H2S production by dividing the net H2S produced
by the incubation time and by the amount of tissue. The rate of
H2S production was expressed as mmol h
- 1 kg of tissue - 1.
The dependence of the H2S pKa on ionic strength in con-
centrated solutions has been reported (2, 16, 26). According to
these reports, the pKa for H2S at 37C decreases from 6.8 in
water to 6.7–6.6 at physiological salt concentrations. To our
knowledge, reliable experimental data on the pKa of H2S at
physiologically relevant ionic conditions has not been re-
ported. Under our experimental conditions, with a gas to
liquid volume ratio of 39:1, most of the H2S in the reaction
mixture is present in the gas phase even at pH 7.4 (*80%).
Thus, our results are not very sensitive to the pKa value used
for H2S and a value of 6.8 was employed in our calculations.
Based on our estimates, a change in the pKa value from 6.8 to
6.6 would lead to a < 10% difference in the H2S amount under
our experimental conditions.
H2S degradation assays
Tissue homogenates were prepared as described above;
0.5 ml of homogenate was placed in a polypropylene syringe
barrel, and the syringe was sealed with a plunger. For an-
aerobic assays, the syringe headspace was flushed five times
with nitrogen using a 3-way stopcock, and then filled with
nitrogen to a total volume (liquid + gas) of 10 ml. Then, 10 ml
of 40 ppm H2S in nitrogen was added to the syringe to give a
final volume of 20 ml. For aerobic assays, the syringe head-
space was filled with air to a total volume (liquid + gas) of
10 ml, and 10 ml of 40 ppm H2S in nitrogen was added, using a
3-way stopcock, to give a total final volume of 20 ml. The total
initial amount of H2S in the syringes was 17.9 nmoles. The
syringes were incubated at room temperature (25C) with
stirring and 200 ll aliquots were collected from the gas phase
for H2S analysis after 1, 2, 3, 5, 10, 15, and 20 min of incuba-
tion. Levels of H2S in the samples were measured as described
above. The amount of H2S in the syringes was calculated
using the ratio between the concentration of H2S in the liquid
and gas phases of 2.0 at 25C (12) and a pKa of 7.0 for ioni-
zation of H2S in water at 25C (16).
In several separate experiments, we compared aerobic
H2S degradation by liver homogenates, prepared with reg-
ular buffers (HEPES pH 7.4, or sodium phosphate pH 5.8) or
with buffers containing the metal chelator, DTPA (8, 22). For
this, frozen liver was divided to two pieces, and the pieces
were homogenized in buffer – 50 lM DTPA. Aerobic H2S
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degradation was analyzed in both homogenates as de-
scribed above.
To analyze the influence of mitochondrial integrity on H2S
degradation kinetics, liver was divided into two equal sec-
tions immediately following collection; one part was imme-
diately frozen in liquid nitrogen and stored on dry ice. The
second part was gently disrupted in 100 mM HEPES buffer,
pH 7.4 at 0C using a glass homogenizer to obtain a tissue
concentration of 100 mg ml - 1. A 0.5 ml aliquot of homogenate
was immediately used for analysis of the kinetics of aerobic
H2S degradation as described above while the rest of ho-
mogenate was stored on ice for 30 or 60 min prior to being
used for analysis of H2S clearance rate. The frozen liver sec-
tion was homogenized with 100 mM HEPES buffer, pH 7.4,
and used for analysis of the kinetics of aerobic H2S degrada-
tion as described above.
For strictly anaerobic assays, buffer, tissue homogenates,
and the reaction mixtures in syringes were prepared in
OMNI-LAB anaerobic chamber (VAC, Hawthorne, CA) filled
with nitrogen. The oxygen levels were *0.2–0.5 ppm. Under
strictly anaerobic conditions, samples for H2S analysis were
only collected after 20 min incubation. In control experiments,
500 ll of buffer (100 mM HEPES, pH 7.4) with or without
different thiol metabolites were placed in a syringe instead of
tissue homogenate.
Antibody production and purification
Polyclonal anti-human ETHE1 chicken antibodies were
developed in Aves Labs (Tigard, OR) against recombinant
human protein purified in our laboratory. The antigen, which
was > 95% pure, was separated on a denaturing 12% poly-
acrylamide gel and the protein band was excised and used for
antibody production. Purified antibodies were obtained using
an affinity resin, prepared by coupling recombinant human
ETHE1 purified in house to Actigel ALT (Sterogene, Carlsbad,
CA) according to vendor’s protocol. Purified antibodies were
used for Western blot analysis in dilution of 1:1000.
Western blot analysis
Frozen tissues were powdered in liquid nitrogen using a
porcelain mortar and pestle and the powder was suspended
in lysis buffer (20 mM HEPES, pH 7.5, 25 mM KCl, 0.5%
NONIDET P-40, 10 ll/ml protease inhibitor cocktail for
mammalian cells and tissue extracts (Sigma), 25 lg/ml
tosyllysine chloromethylketone, and 17 lg/ml phenylme-
thylsulfonyl fluoride). The protein concentration in tissue
extracts was determined using the Bradford assay and bovine
serum albumin as standard as described previously (14).
Proteins were resolved on 12% SDS-polyacrylamide gels and
transferred to PVDF membranes. Blots were probed with
polyclonal anti-human ETHE1 chicken antibodies. Secondary
anti-chicken antibodies conjugated with horseradish peroxi-
dase (Aves Labs) were used (1:250,000 dilution) and signals
were visualized using the chemiluminescent peroxidase
substrate kit (SuperSignal West Dura (Thermo Scientific)).
Statistical analysis and kinetic fits
Statistical analysis and exponential fits of kinetic data
were performed using Origin 7 software (OriginLab, North-
ampton, MA). Data are presented as mean – SD.
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